Outpatient Pharmacy Services

Tender

Portsmouth Hospitals University NHS Trust

Highlights

Tender deadline
31 Dec 2026
Estimated value
£30,700,000
Location
UKJ31

Details

Published
10 Nov 2026
Tender deadline
31 Dec 2026
Value
£30,700,000
Location
UKJ31
Source
Find a Tender
Source notice ID
106870-2026
OCID
ocds-h6vhtk-07b8fd
CPV codes
85149000
View on Find a Tender

Description

Delivery of the outpatient pharmacy services within the Queen Alexandra hospital at Portsmouth Hospitals University NHS Trust.

Similar opportunities

More from Portsmouth Hospitals University NHS Trust

View all

Lots (1)

LotTitleValue
1Outpatient Pharmacy Services - Procurement approach. The current contract is due to expire on the 31st of January 2027 The contract was novated to Rowlands Pharmacy LTD for 2 years, for a total Value of circa £28,000,000 The Contracting Authority is to undertake a Direct Award Process C under the PSR regulations and award a new contract to the incumbent supplier until a competitive process can be awarded. The key criteria to award a contract via award Direct Award Process has been analysed by thOutpatient Pharmacy Services - Procurement approach. The current contract is due to expire on the 31st of January 2027 The contract was novated to Rowlands Pharmacy LTD for 2 years, for a total Value of circa £28,000,000 The Contracting Authority is to undertake a Direct Award Process C under the PSR regulations and award a new contract to the incumbent supplier until a competitive process can be awarded. The key criteria to award a contract via award Direct Award Process has been analysed by the Pharmacy department. Key observations include the following. The provider is already established in the Trust and has a good working relationship with Pharmacy Care Group. To date there have been no serious incidents or harm reported related to the service. To continue with this provider reduces the risk of service disruption and patient harm that may otherwise arise from a rapidly expedited change in provider. The provider continues to monitor and respond to any safety learning events or complaints in collaboration with the Medication Safety Team and the wider Pharmacy Care Group to ensure patient safety. They also support patients through medication counselling and advice£30,700,000